{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:06:36Z","timestamp":1777493196377,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,9]]},"DOI":"10.7759\/cureus.59999","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T01:28:30Z","timestamp":1715304510000},"source":"Crossref","is-referenced-by-count":2,"title":["COVID-19 mRNA Vaccination-Induced Myopericarditis in an Otherwise Healthy Young Male: An Evidence-Based Approach to Differentiating From Perimyocarditis"],"prefix":"10.7759","author":[{"given":"Lekhini","family":"Latchupatula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myles","family":"Benayon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Ganame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikas","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio AL","year":"2013","unstructured":"Caforio AL, Pankuweit S, Arbustini E, et al.. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013, 34:2636-48, 2648a-2648d. 10.1093\/eurheartj\/eht210","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"36","author":"Adler Y","year":"2015","unstructured":"Adler Y, Charron P, Imazio M, et al.. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: the task force for the diagnosis and management of pericardial diseases of the European Society of Cardiology (ESC) endorsed by: the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015, 36:2921-64. 10.1093\/eurheartj\/ehv318","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11144123","article-title":"Influenza myopericarditis and pericarditis: a literature review","volume":"11","author":"Radovanovic M","year":"2022","unstructured":"Radovanovic M, Petrovic M, Barsoum MK, et al.. Influenza myopericarditis and pericarditis: a literature review. J Clin Med. 2022, 11:4123. 10.3390\/jcm11144123","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/piab061","article-title":"Weighing the risks of perimyocarditis with the benefits of SARS-CoV-2 mRNA vaccination in adolescents","volume":"10","author":"Jhaveri R","year":"2021","unstructured":"Jhaveri R, Adler-Shohet FC, Blyth CC, et al.. Weighing the risks of perimyocarditis with the benefits of SARS-CoV-2 mRNA vaccination in adolescents. J Pediatric Infect Dis Soc. 2021, 10:937-9. 10.1093\/jpids\/piab061","journal-title":"J Pediatric Infect Dis Soc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00059-5","article-title":"Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis","volume":"10","author":"Ling RR","year":"2022","unstructured":"Ling RR, Ramanathan K, Tan FL, Tai BC, Somani J, Fisher D, MacLaren G. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis. Lancet Respir Med. 2022, 10:679-88. 10.1016\/S2213-2600(22)00059-5","journal-title":"Lancet Respir Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.12.046","article-title":"Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018","volume":"39","author":"Su JR","year":"2021","unstructured":"Su JR, McNeil MM, Welsh KJ, Marquez PL, Ng C, Yan M, Cano MV. Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018. Vaccine. 2021, 39:839-45. 10.1016\/j.vaccine.2020.12.046","journal-title":"Vaccine"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00791-7","article-title":"Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases","volume":"399","author":"Wong HL","year":"2022","unstructured":"Wong HL, Hu M, Zhou CK, et al.. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases. Lancet. 2022, 399:2191-9. 10.1016\/S0140-6736(22)00791-7","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.05.048","article-title":"Myocarditis and\/or pericarditis risk after mRNA COVID-19 vaccination: a Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines","volume":"40","author":"Abraham N","year":"2022","unstructured":"Abraham N, Spruin S, Rossi T, et al.. Myocarditis and\/or pericarditis risk after mRNA COVID-19 vaccination: a Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines. Vaccine. 2022, 40:4663-71. 10.1016\/j.vaccine.2022.05.048","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2110737","article-title":"Myocarditis after Covid-19 vaccination in a large health care organization","volume":"385","author":"Witberg G","year":"2021","unstructured":"Witberg G, Barda N, Hoss S, et al.. Myocarditis after Covid-19 vaccination in a large health care organization. N Engl J Med. 2021, 385:2132-9. 10.1056\/NEJMoa2110737","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.4768","article-title":"Myopericarditis after COVID-19 mRNA vaccination among adolescents and young adults: a systematic review and meta-analysis","volume":"177","author":"Yasuhara J","year":"2023","unstructured":"Yasuhara J, Masuda K, Aikawa T, Shirasu T, Takagi H, Lee S, Kuno T. Myopericarditis after COVID-19 mRNA vaccination among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr. 2023, 177:42-52. 10.1001\/jamapediatrics.2022.4768","journal-title":"JAMA Pediatr"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14322","article-title":"Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report","volume":"28","author":"McLean K","year":"2021","unstructured":"McLean K, Johnson TJ. Myopericarditis in a previously healthy adolescent male following COVID-19 vaccination: A case report. Acad Emerg Med. 2021, 28:918-21. 10.1111\/acem.14322","journal-title":"Acad Emerg Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e277","article-title":"A case report for myopericarditis after BNT162b2 COVID-19 mRNA vaccination in a Korean young male","volume":"36","author":"Kim D","year":"2021","unstructured":"Kim D, Choi JH, Jang JY, et al.. A case report for myopericarditis after BNT162b2 COVID-19 mRNA vaccination in a Korean young male. J Korean Med Sci. 2021, 36:e277. 10.3346\/jkms.2021.36.e277","journal-title":"J Korean Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytac298","article-title":"Case report: mRNA COVID-19 vaccine-related acute pericarditis with evolution to myopericarditis","volume":"6","author":"Riddell C","year":"2022","unstructured":"Riddell C, Edwards NC, Stewart R. Case report: mRNA COVID-19 vaccine-related acute pericarditis with evolution to myopericarditis. Eur Heart J Case Rep. 2022, 6:ytac298. 10.1093\/ehjcr\/ytac298","journal-title":"Eur Heart J Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.09.008","article-title":"The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology","volume":"50","author":"Cooper LT","year":"2007","unstructured":"Cooper LT, Baughman KL, Feldman AM, et al.. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol. 2007, 50:1914-31. 10.1016\/j.jacc.2007.09.008","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12092104","article-title":"Role of endomyocardial biopsy in diagnostics of myocarditis","volume":"12","author":"Vidusa L","year":"2022","unstructured":"Vidusa L, Kalejs O, Maca-Kaleja A, Strumfa I. Role of endomyocardial biopsy in diagnostics of myocarditis. Diagnostics (Basel). 2022, 12:2104. 10.3390\/diagnostics12092104","journal-title":"Diagnostics (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000455","article-title":"Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt B","year":"2016","unstructured":"Bozkurt B, Colvin M, Cook J, et al.. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association. Circulation. 2016, 134:e579-646. 10.1161\/CIR.0000000000000455","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira VM","year":"2018","unstructured":"Ferreira VM, Schulz-Menger J, Holmvang G, et al.. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018, 72:3158-76. 10.1016\/j.jacc.2018.09.072","journal-title":"J Am Coll Cardiol"},{"key":"ref18","article-title":"Coxsackievirus B3 murine myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents","volume":"107","author":"Rezkalla S","year":"1986","unstructured":"Rezkalla S, Khatib G, Khatib R. Coxsackievirus B3 murine myocarditis: deleterious effects of nonsteroidal anti-inflammatory agents. J Lab Clin Med. 1986, 107:393-5.","journal-title":"J Lab Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5772\/19291","article-title":"Perimyocarditis","author":"Omar HR","year":"2011","unstructured":"Omar HR, Abdelmalak H, Helal E,  Fathy A. Perimyocarditis. Myocarditis. Cihakova D (ed): IntechOpen, London, UK; 2011. 10.5772\/19291"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/imj.15748","article-title":"COVID-19 mRNA vaccines and myopericarditis","volume":"53","author":"Gnanenthiran SR","year":"2023","unstructured":"Gnanenthiran SR, Limaye S. COVID-19 mRNA vaccines and myopericarditis. Intern Med J. 2023, 53:172-7. 10.1111\/imj.15748","journal-title":"Intern Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/253293-covid-19-mrna-vaccination-induced-myopericarditis-in-an-otherwise-healthy-young-male-an-evidence-based-approach-to-differentiating-from-perimyocarditis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T01:28:33Z","timestamp":1715304513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/253293-covid-19-mrna-vaccination-induced-myopericarditis-in-an-otherwise-healthy-young-male-an-evidence-based-approach-to-differentiating-from-perimyocarditis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.59999","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,9]]}}}